M&A Deal Summary |
|
|---|---|
| Date | 2025-08-27 |
| Target | Advent Bioservices |
| Sector | Life Science |
| Buyer(s) | Northwest Biotherapeutics |
| Deal Type | Add-on Acquisition |
SEARCH BY
Northwest Biotherapeutics, Inc. is a biotechnology company focused on developing personalized immunotherapy products designed to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis, in both North America and Europe.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| Country: United Kingdom M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-09-01 |
Flaskworks
Boston, Massachusetts, United States Flaskworks LLC is a manufacturer of immune cell therapies (including T cell therapies and others). Flaskworks is based in Boston, Massachusetts. |
Buy | $4M |